Citadel Advisors’s Red Violet RDVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$312K Buy
+4,900
New +$232K ﹤0.01% 11025
2025
Q2
Sell
-1,500
Closed -$56.4K 14638
2025
Q1
$56.4K Sell
1,500
-1,000
-40% -$37.7K ﹤0.01% 12179
2024
Q4
$90.5K Sell
2,500
-1,200
-32% -$40K ﹤0.01% 11624
2024
Q3
$105K Buy
3,700
+500
+16% +$13.6K ﹤0.01% 11048
2024
Q2
$81.3K Sell
3,200
-600
-16% -$12.1K ﹤0.01% 11190
2024
Q1
$74.3K Buy
3,800
+400
+12% +$7.33K ﹤0.01% 11746
2023
Q4
$67.9K Sell
3,400
-3,400
-50% -$67.8K ﹤0.01% 11421
2023
Q3
$136K Buy
6,800
+1,400
+26% +$29K ﹤0.01% 10505
2023
Q2
$111K Buy
+5,400
New +$101K ﹤0.01% 10771

Other funds holding RDVT

Citadel Advisors's RDVT Position: Q2 2026 in Review

Citadel Advisors reduced its Red Violet (RDVT) stake by 6.4% in Q2 2026, selling an estimated $166K and leaving 50,914 shares worth $3.24M. The position accounts for ﹤0.01% of the portfolio, ranked #5545.

Citadel Advisors first reported a position in RDVT in Q1 2018 and has held it in 20 quarters since. The position peaked at $3.62M in Q2 2025. 173 funds tracked by Wall St. Rank hold RDVT as of Q2 2026.

  • Citadel Advisors held 50,914 shares of Red Violet worth $3.24M as of Q2 2026.
  • Citadel Advisors sold 3,504 Red Violet shares in Q2 2026, an estimated $166K.
  • Red Violet made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #5545 holding.
  • Citadel Advisors first reported a position in Red Violet in Q1 2018 and has held it in 20 quarters since.
  • Citadel Advisors's Red Violet position peaked at $3.62M in Q2 2025.
  • 173 funds tracked by Wall St. Rank held Red Violet as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.